Our Pricing

Weight Loss Injections in Neath: Evidence-Based Treatment Options

Published: 1 October 2026

Weight loss injections Neath residents can access through Cured Pharmacy include clinically proven GLP-1 receptor agonists such as Mounjaro, Wegovy, and Saxenda, all requiring assessment by a UK-registered prescriber. Our pharmacy serves patients across Neath Port Talbot with genuine UK-licensed medications, transparent pricing from £124.99, and discreet home delivery. Every prescription treatment begins with a free online consultation completed in under three minutes, ensuring safe and appropriate care tailored to your weight management goals.

What Are Weight Loss Injections Neath Patients Can Access?

Weight loss injections Neath residents commonly request include three main categories of GLP-1 receptor agonists: tirzepatide (Mounjaro), semaglutide (Wegovy), and liraglutide (Saxenda). These medications work by mimicking natural gut hormones that regulate appetite, slow gastric emptying, and improve insulin sensitivity [1]. Clinical trials demonstrate that tirzepatide can lead to average weight reductions of up to 20.9% of body weight over 72 weeks, whilst semaglutide achieves approximately 14.9% weight loss in the STEP 1 trial [2].

Each injection type requires subcutaneous administration, typically in the abdomen, thigh, or upper arm, with frequency varying from once daily (Saxenda) to once weekly (Mounjaro and Wegovy). All prescription weight loss injections available through Cured Pharmacy are MHRA-approved and dispensed only after clinical assessment by our UK-registered prescribers, ensuring patient safety and treatment suitability. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), oversees every prescription to maintain the highest standards of pharmaceutical care.

How Weight Loss Injections Neath Services Work at Cured Pharmacy

Accessing weight loss injections Neath patients need begins with our streamlined online consultation process, designed to replicate the thoroughness of an in-person GP assessment whilst offering greater convenience. You complete a detailed medical questionnaire covering your weight history, current medications, cardiovascular health, and treatment goals—typically finished in under three minutes. Our UK-registered prescribers review every submission individually, assessing contraindications such as personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastroparesis.

Once approved, your prescription is dispensed from our GPhC-registered pharmacy (9012511) and shipped in 100% discreet packaging, with most orders arriving within 1-2 working days across Neath and surrounding areas. We provide transparent pricing before you begin the consultation—Mounjaro starts at £124.99, with £20 off your first order using code Weightlossnew. Every patient receives ongoing support, including dosage titration guidance and access to our clinical team for questions about injection technique, side effect management, or treatment adjustments.

Eligibility Criteria for Weight Loss Injections

Weight loss injections are typically prescribed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Our prescribers assess each case individually, considering factors like previous weight loss attempts, motivation for lifestyle changes, and any medical conditions that might affect treatment safety. Patients must be willing to commit to dietary modifications and increased physical activity, as medications work best when combined with behavioural interventions.

Comparing Weight Loss Injections Neath Options: Mounjaro vs Wegovy vs Saxenda

Weight loss injections Neath patients choose between differ significantly in mechanism, efficacy, and dosing schedules. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, offering the highest average weight loss in clinical trials—up to 20.9% body weight reduction in the SURMOUNT-1 study [1]. Wegovy (semaglutide) is a selective GLP-1 receptor agonist with robust evidence showing 14.9% average weight loss over 68 weeks [2]. Saxenda (liraglutide), an earlier-generation GLP-1 agonist, demonstrates approximately 8% weight loss but requires daily injections rather than weekly administration.

Choosing between these options depends on individual factors including weight loss goals, tolerance for injection frequency, previous medication responses, and budget. Mounjaro's dual-agonist mechanism may provide superior glycaemic control for patients with prediabetes or type 2 diabetes, whilst Wegovy offers a well-established safety profile with extensive real-world data. Our prescribers guide Neath patients through this decision during the online consultation, considering your medical history and treatment preferences to recommend the most suitable option.

Side Effects and Safety Considerations

Common side effects across all weight loss injections include nausea, diarrhoea, vomiting, constipation, and abdominal discomfort, typically most pronounced during the initial titration phase [4]. These gastrointestinal symptoms usually diminish over 4-8 weeks as the body adapts to treatment. More serious but rare risks include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking concurrent diabetes medications). All GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans [3].

Pricing for Weight Loss Injections Neath Residents at Cured Pharmacy

Weight loss injections Neath patients access through Cured Pharmacy start at £124.99 for Mounjaro, with transparent pricing displayed before you begin the consultation process. We guarantee the lowest UK prices, with no hidden fees or surprise charges at checkout. New patients receive £20 off their first order using code Weightlossnew, reducing the initial investment and making evidence-based weight management more accessible across Neath Port Talbot.

Our pricing includes the medication, UK prescriber consultation, and discreet home delivery—everything needed to begin treatment safely. Unlike some providers who advertise low headline prices but add consultation fees, delivery charges, or mandatory subscription commitments, Cured Pharmacy maintains upfront transparency. We offer flexible supply options from single pens to multi-month packages, allowing you to choose the option that best fits your budget and treatment timeline. All prices reflect genuine UK-licensed medications dispensed from our GPhC-registered facility.

Clinical Evidence Supporting Weight Loss Injections Neath Prescribers Recommend

Weight loss injections Neath prescribers recommend are backed by extensive randomised controlled trials demonstrating both efficacy and safety. The SURMOUNT-1 trial enrolled 2,539 adults with obesity and showed tirzepatide 15mg once weekly resulted in mean weight loss of 20.9% compared to 3.1% with placebo over 72 weeks [1]. Similarly, the STEP 1 trial of semaglutide 2.4mg weekly in 1,961 adults demonstrated 14.9% weight reduction versus 2.4% with placebo at 68 weeks [2].

Beyond weight loss, these medications improve cardiometabolic markers including HbA1c, systolic blood pressure, and lipid profiles [4]. The SELECT cardiovascular outcomes trial showed semaglutide reduced major adverse cardiovascular events by 20% in adults with established cardiovascular disease and overweight or obesity, leading to expanded prescribing indications [5]. This evidence base informs our prescribers' recommendations, ensuring Neath patients receive treatments with proven benefits extending beyond the number on the scale.

Long-Term Weight Maintenance and Treatment Duration

Clinical trials indicate that weight loss injections work best as long-term treatments rather than short-term interventions. The STEP 4 trial demonstrated that patients who discontinued semaglutide after 20 weeks regained approximately two-thirds of their lost weight over the subsequent 48 weeks [6]. This underscores the importance of viewing these medications as chronic disease management tools, similar to treatments for hypertension or high cholesterol. Our prescribers discuss realistic treatment timelines during consultations, typically recommending at least 12-24 months of therapy combined with sustainable lifestyle modifications to achieve lasting results.

Why Choose Cured Pharmacy for Weight Loss Injections Neath Delivery

Weight loss injections Neath residents order through Cured Pharmacy benefit from our commitment to pharmaceutical excellence, regulatory compliance, and patient-centred care. As a fully registered UK pharmacy (GPhC 9012511) with superintendent pharmacist Tarun Kumar overseeing operations, we maintain the same rigorous standards as traditional high-street pharmacies whilst offering the convenience of online access. Every medication is sourced directly from UK-licensed wholesalers, guaranteeing authenticity and proper storage throughout the supply chain.

Our service model prioritises transparency and support at every stage. You see exact pricing before beginning the consultation, receive clear guidance on injection technique and dose escalation, and can contact our clinical team with questions throughout your treatment journey. We serve patients across Neath, Port Talbot, Swansea, and throughout Wales with discreet home delivery, typically within 1-2 working days. Our free online consultation takes under three minutes to complete, with most prescriptions reviewed and approved the same day, ensuring you can begin your weight management journey without unnecessary delays.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 1 October 2026]
2. Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 1 October 2026]
3. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE Guidelines. [accessed 1 October 2026]
4. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 1 October 2026]
5. Lincoff, A. M., Brown-Frandsen, K., Colhoun, H. M., et al. (2023). Semaglutide and cardiovascular outcomes in obesity without diabetes. New England Journal of Medicine, 389(24), 2221-2232. [accessed 1 October 2026]
6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 1 October 2026]
7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 1 October 2026.
8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 1 October 2026.
9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 1 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.